+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunosorbent Assay"

From
Autoimmune Immunoassay Brief - Product Thumbnail Image

Autoimmune Immunoassay Brief

  • Report
  • January 2022
  • 71 Pages
  • Global
From
In-vitro Diagnostics Global Market- Forecast to 2027 - Product Thumbnail Image

In-vitro Diagnostics Global Market- Forecast to 2027

  • Report
  • September 2021
  • 792 Pages
  • Global
From
Cancer Diagnostics Global Market-Forecast of 2026 - Product Thumbnail Image

Cancer Diagnostics Global Market-Forecast of 2026

  • Report
  • June 2020
  • 404 Pages
  • Global
From
Global Protein Assays Market: Impact of COVID-19 - Product Thumbnail Image

Global Protein Assays Market: Impact of COVID-19

  • Report
  • October 2020
  • 79 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body. The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems. Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more